Oppenheimer Holdings Stock News

These four stocks are all trading below their book value, making it likely that their names are showing up on the value screens of large institutional investors. Since each one trades on the New York

Blade Air Mobility, Inc. (NASDAQ:BLDE) – Research analysts at Oppenheimer issued their FY2026 earnings estimates for Blade Air Mobility in a report released on Tuesday, December 21st. Oppenheimer analyst J. Helfstein forecasts that the company will post earnings per share of ($0.33) for the year. Oppenheimer currently has a “Outperform” rating and a $14.00 price […] The post Oppenheimer Weighs in on Blade Air Mobility, Inc.’s FY2026 Earnings (NASDAQ:BLDE) appeared first on ETF Daily News .

Global Blood Therapeutics, Inc. (NASDAQ:GBT) Investment analysts at Oppenheimer cut their Q1 2022 earnings per share estimates for shares of Global Blood Therapeutics in a research note issued on Monday, December 20th. Oppenheimer analyst M. Breidenbach now expects that the company will post earnings of ($1.07) per share for the quarter, down from their [] The post Q1 2022 Earnings Forecast for Global Blood Therapeutics, Inc. (NASDAQ:GBT) Issued By Oppenheimer appeared first on ETF Daily News .

Oppenheimer named cryptocurrency exchange Coinbase Global Inc (NASDAQ: COIN ) a top pick for 2022 Wednesday, citing the continued adoption of digital assets by retailers and institutions. "For institutional investors who are interested in getting exposure to digital assets, we believe COIN is well-positioned to benefit from it," Oppenheimer analyst Owen Lau said. Ritholtz Wealth Management CEO Josh Brown weighed in Wednesday afternoon on CNBC''s "Closing Bell." "This is the most obvious play in the stock market right now as far as a directional bet on whether or not there will be huge flows into crypto from institutions and wealth management next year," Brown said. "And I know there will Full story available on Benzinga.com

Oppenheimer is out with its 2022 picks and Coinbase (NASDAQ:COIN) has made the list. The analyst providing the coverage has set a $444 price target for the crypto exchange, a significant increase over its current per-share price that hovers around $252/share. Coinbase became a public Read More

Next year will be a stock-picker''s market, and these clean energy companies hold up well on a fundamental basis, according to Oppenheimer.

Oppenheimer initiated cover Latest Ratings for ACST Date Firm Action From To Dec 2021 Oppenheimer Initiates Coverage On Outperform Dec 2021 Oppenheimer Initiates Coverage Full story available on Benzinga.com

Global Blood Therapeutics, Inc. (NASDAQ:GBT) Analysts at Oppenheimer dropped their Q1 2022 earnings estimates for Global Blood Therapeutics in a report issued on Monday, December 20th. Oppenheimer analyst M. Breidenbach now expects that the company will post earnings of ($1.07) per share for the quarter, down from their previous forecast of ($1.03). Oppenheimer also []

According to the head of technical analysis at Oppenheimer, the second A in FAANG requires closer attention among the other FAANG stocks.

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its price objective hoisted by Royal Bank of Canada from $32.00 to $34.00 in a research note released on Tuesday, Price Targets.com reports. Royal Bank of Canada currently has an outperform rating on the biopharmaceutical companys stock. A number of other research analysts also recently issued reports on ACAD. Oppenheimer boosted [] The post ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target Increased to $34.00 by Analysts at Royal Bank of Canada appeared first on ETF Daily News .

FedEx Co. (NYSE:FDX) Equities researchers at Oppenheimer increased their Q3 2022 EPS estimates for FedEx in a note issued to investors on Friday, December 17th. Oppenheimer analyst S. Schneeberger now expects that the shipping service provider will post earnings of $4.68 per share for the quarter, up from their prior forecast of $4.59. Oppenheimer [] The post Q3 2022 Earnings Estimate for FedEx Co. Issued By Oppenheimer (NYSE:FDX) appeared first on ETF Daily News .

WW International, Inc. (NASDAQ:WW) Stock analysts at Oppenheimer issued their Q4 2021 earnings per share estimates for WW International in a research note issued to investors on Thursday, December 16th. Oppenheimer analyst B. Nagel expects that the company will earn $0.32 per share for the quarter. Oppenheimer also issued estimates for WW Internationals FY2023 []

Nordson Co. - Oppenheimer upped their Q1 2022 earnings estimates for Nordson in a research note issued to investors on Thursday, December 16th. Oppenheimer analyst C. Glynn now

Freshpet (NASDAQ:FRPT) had its target price cut by equities research analysts at Oppenheimer from $175.00 to $120.00 in a research note issued on Monday, Price Targets.com reports. The firm currently has an outperform rating on the stock. Oppenheimers price target points to a potential upside of 23.46% from the companys previous close. Other research analysts []

WW International, Inc. (NASDAQ:WW) Oppenheimer issued their Q4 2021 earnings per share estimates for shares of WW International in a report issued on Thursday, December 16th. Oppenheimer analyst B. Nagel forecasts that the company will post earnings of $0.32 per share for the quarter. Oppenheimer also issued estimates for WW Internationals FY2023 earnings at []